- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04719624
Novel Porous Bioceramic Material as a Bone Substitute
Novel Porous Bioceramic Material as a Bone Substitute. Clinical Trial.
The aim of this study is to demonstrate that new synthetic bone graft bioceramic composites (Adaptos®-Si and Adaptos®, Biomendex Oy) are able to support the preservation of the alveolar ridge and to promote bone regeneration following dental extraction. New bone graft substitutes are compared with already existing treatment principles used following dental extraction.
The primary hypothesis of the study is that Adaptos®-Si granules can reach a clinical outcome superior to that of dental socket left empty after extraction. Secondary aim is that new bioceramic composites can reach a clinical outcome non inferior to the active comparator of this study (Geistlisch Bio-Oss®).
Study Overview
Status
Conditions
Detailed Description
The purpose of this study is to evaluate new synthetic Adaptos®-Si and Adaptos® in ridge preservation bone grafting after dental extraction. This is partly randomized, subject and outcome assessor-blinded, controlled, single center study. The total study duration for each patient is planned to be 10 months. In total 4 visits per patient are scheduled in this study.
Subjects will undergo a single tooth extraction and then will be randomized to receive one of the four bone graft substitutes, which are Adaptos®-Si (one of the the two granula sizes), Adaptos®, or Geistlich Bio-Oss®. Gelatin sponge is applied on the bone graft filled extraction socket. Non-randomized part of the study includes the patients that have chosen the conservative treatment option with dental socket left empty and no intention for dental implant placement. Following a healing period of 5 months, a dental implant will be placed, unless the patient has chosen the empty socket. The subject will be followed for ten months following tooth extraction. Bone ridge horizontal and vertical change assessment will be done by CBCT (primary and secondary outcome) at the time of tooth extraction, and 5 months and 10 months post-extraction.
The study device Bio-Oss® (Geistlich Pharma) and Spongostan Absorbable Haemostatic Gelatin Sponge (Ferrosan Medical Devices) are CE-marked. The products are used within the indication.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Helsinki, Finland, 00170
- Oral Hammaslääkärit Oyj, Qmedical Pikku Huopalahti
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patient must have voluntarily signed the informed consent
- Females and males, 18 years to 80 years of age
- Patient needs single tooth extraction of 1st or 2nd premolar or molar tooth
- At least one adjacent teeth present
- At least 3 intact walls
- Subjects must be committed to the study and the required follow-up visits
Exclusion Criteria:
- Planned radiation or radiation during previous year in the tooth extraction area.
- Smoking
- Osteoporosis
- Uncontrolled periodontitis
- Alcohol or drug abuse
- Pregnant or breastfeeding women
- Uncontrolled diabetes
- Local acute or chronic infection or presence of oral lesions or trauma
- Immunosuppressive disease, treatment, or medication
- Subject is part of the investigator team of this study or investigator's family member
- Subject is employee of one of the organizations involve in this study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Adaptos-Si [0.5-1 mm]
Bone augmentation, after tooth extraction, with Adaptos-Si [0.5-1 mm] (synthetic bone graft material) in combination with a gelatin sponge.
|
After screening and enrollment, subjects will undergo tooth extraction of a single tooth with placement of one of the four randomized, synthetic bone graft substitutes with a gelatin sponge (Spongostan Dental).
Following 5 months of healing a dental implant will be placed.
The subjects will then be followed for another 5 months for healing.
Follow-up visits will be at 2 weeks, 5 months, and 10 months.
Other Names:
|
|
Experimental: Adaptos-Si [1-2 mm]
Bone augmentation, after tooth extraction, with Adaptos-Si [1-2 mm] (synthetic bone graft material) in combination with a gelatin sponge.
|
After screening and enrollment, subjects will undergo tooth extraction of a single tooth with placement of one of the four randomized, synthetic bone graft substitutes with a gelatin sponge (Spongostan Dental).
Following 5 months of healing a dental implant will be placed.
The subjects will then be followed for another 5 months for healing.
Follow-up visits will be at 2 weeks, 5 months, and 10 months.
Other Names:
|
|
Active Comparator: Bio-Oss
Bone augmentation, after tooth extraction, with Bio-Oss (bovine-derived xenograft) in combination with a gelatin sponge.
|
After screening and enrollment, subjects will undergo tooth extraction of a single tooth with placement of one of the four randomized, synthetic bone graft substitutes with a gelatin sponge (Spongostan Dental).
Following 5 months of healing a dental implant will be placed.
The subjects will then be followed for another 5 months for healing.
Follow-up visits will be at 2 weeks, 5 months, and 10 months.
Other Names:
|
|
Placebo Comparator: Empty extraction socket
Post-extraction the socket filled only by clot.
|
After screening and enrollment, subjects will undergo tooth extraction of a single tooth and the socket is filled only by clot.
Subject will be followed at 2 weeks, 5 months, and 10 months for healing.
|
|
Experimental: Adaptos [1-2 mm]
Bone augmentation, after tooth extraction, with Adaptos [1-2 mm] (synthetic bone graft material) in combination with a gelatin sponge.
|
After screening and enrollment, subjects will undergo tooth extraction of a single tooth with placement of one of the four randomized, synthetic bone graft substitutes with a gelatin sponge (Spongostan Dental).
Following 5 months of healing a dental implant will be placed.
The subjects will then be followed for another 5 months for healing.
Follow-up visits will be at 2 weeks, 5 months, and 10 months.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alveolar ridge preservation, comparison between Adaptos-Si filled extraction sockets and empty sockets.
Time Frame: baseline, 5 months, and 10 months post-extraction
|
Alveolar ridge horizontal and vertical change assessment by cone-beam computed tomography (CBCT).
The vertical reference line is outlined from the apex through the center of the socket and the horizontal reference line through the apex perpendicular to the vertical line.
The ridge width (in mm) is measured parallel to the horizontal reference line 1 mm, 3 mm, and 5 mm from the highest buccal ridge point on baseline.
Ridge heights (in mm) are measured from the most apical point of the alveolar socket parallel to the vertical reference line.
The dimensional changes of the ridge assessed on CBCT images immediately post-extraction, are acquired five months and ten months later.
Comparison between Adaptos-Si filled extraction sockets and empty sockets.
|
baseline, 5 months, and 10 months post-extraction
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alveolar ridge horizontal and vertical change (in mm) assessment by CBCT, comparisons between extraction sockets filled with Adaptos-Si or Bio-Oss bone graft substitutes.
Time Frame: baseline, 5 months, and 10 months post-extraction
|
Alveolar ridge horizontal and vertical change assessment by cone-beam computed tomography (CBCT).
The vertical reference line is outlined from the apex through the center of the socket and the horizontal reference line through the apex perpendicular to the vertical line.
The ridge width (in mm) is measured parallel to the horizontal reference line 1 mm, 3 mm, and 5 mm from the highest buccal ridge point on baseline.
Ridge heights (in mm) are measured from the most apical point of the alveolar socket parallel to the vertical reference line.
The dimensional changes of the ridge assessed on CBCT images immediately post-extraction, are acquired five months and ten months later.
Comparison between extraction sockets filled with Adaptos-Si or Bio-Oss bone graft substitutes.
|
baseline, 5 months, and 10 months post-extraction
|
|
Alveolar ridge horizontal and vertical change (in mm) assessment by CBCT, comparison between Adaptos filled extraction sockets and empty sockets.
Time Frame: baseline, 5 months, and 10 months post-extraction
|
Alveolar ridge horizontal and vertical change assessment by cone-beam computed tomography (CBCT).
The vertical reference line is outlined from the apex through the center of the socket and the horizontal reference line through the apex perpendicular to the vertical line.
The ridge width (in mm) is measured parallel to the horizontal reference line 1 mm, 3 mm, and 5 mm from the highest buccal ridge point on baseline.
Ridge heights (in mm) are measured from the most apical point of the alveolar socket parallel to the vertical reference line.
The dimensional changes of the ridge assessed on CBCT images immediately post-extraction, are acquired five months and ten months later.
Comparison between Adaptos filled extraction sockets and empty sockets.
|
baseline, 5 months, and 10 months post-extraction
|
|
Alveolar ridge horizontal and vertical change (in mm) assessment by CBCT, comparison between extraction sockets filled with Adaptos-Si or Adaptos bone graft substitutes.
Time Frame: baseline, 5 months, and 10 months post-extraction
|
Alveolar ridge horizontal and vertical change assessment by cone-beam computed tomography (CBCT).
The vertical reference line is outlined from the apex through the center of the socket and the horizontal reference line through the apex perpendicular to the vertical line.
The ridge width (in mm) is measured parallel to the horizontal reference line 1 mm, 3 mm, and 5 mm from the highest buccal ridge point on baseline.
Ridge heights (in mm) are measured from the most apical point of the alveolar socket parallel to the vertical reference line.
The dimensional changes of the ridge assessed on CBCT images immediately post-extraction, are acquired five months and ten months later.
Comparison between extraction sockets filled with Adaptos-Si or Adaptos bone graft substitutes.
|
baseline, 5 months, and 10 months post-extraction
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comparison between radiological assessment methods
Time Frame: baseline, 5 months, and 10 months post-extraction
|
The ridge width and height are measured from 2D images of CBCT scans (in mm) and change in dimensions in time is determined using these measurements.
Reduction is also measured directly on the superimposed baseline and follow-up CBCT scans (in mm).The vertical reference line is outlined from the apex through the center of the socket and the horizontal reference line through the apex perpendicular to the vertical line.
The ridge width (in mm) is measured parallel to the horizontal reference line 1 mm, 3 mm, and 5 mm from the highest buccal ridge point on baseline.
Ridge heights (in mm) are measured from the most apical point of the alveolar socket parallel to the vertical reference line.
|
baseline, 5 months, and 10 months post-extraction
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Antero Salo, MD, DDS, PhD, Oral Hammaslääkärit Oy, Qmedical Pikku Huopalahti
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- AdaptosOral-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alveolar Ridge Preservation
-
Cairo UniversityNot yet recruitingSocket Preservation, Alveolar Ridge Deficiency, Alveolar Ridge Preservation
-
Cairo UniversityNot yet recruitingSocket Preservation | Alveolar Ridge PreservationEgypt
-
University of Maryland, BaltimoreNot yet recruiting
-
Yasmine FouadCompletedAlveolar Ridge Preservation
-
Mimetis Biomaterials S.L.Active, not recruitingAlveolar Ridge PreservationChile, Spain
-
University of California, San FranciscoCompletedAlveolar Ridge Preservation
-
Cairo UniversityNot yet recruitingAlveolar Ridge PreservationEgypt
-
Soaad Tolba Mohammed Tolba BadawiCompletedAlveolar Ridge PreservationEgypt
-
Hams Hamed AbdelrahmanCompleted
-
Cairo UniversityCompletedSocket Preservation | Wound Healing | Alveolar Ridge PreservationEgypt
Clinical Trials on Adaptos®-Si [0.5-1 mm] (bone grafting surgery)
-
Biomendex OyActive, not recruitingKnee DeformityFinland, Hungary
-
M3 HealthUniversidade Estadual Paulista Júlio de Mesquita FilhoRecruiting
-
IpsenCompletedMetastatic Adenocarcinoma of the PancreasUnited States, Spain, Hungary, France, Italy, Portugal, United Kingdom, Austria, Germany, Israel, Australia, Brazil, Greece, Czechia, Canada, Belgium, South Korea, Russia
-
Yuhan CorporationLinical KoreaTerminatedA Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic SyndromeMetabolic SyndromeKorea, Republic of
-
Roswell Park Cancer InstituteRecruitingBorderline Resectable Pancreatic Ductal AdenocarcinomaUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompleted
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingStage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic AdenocarcinomaUnited States